Kemal Malik

Insider Reports History

Entity
Individual
Location
C/O Acceleron Pharma Inc., 128 Sidney Street, Cambridge, MA
Signature
/s/ Matthew Bartholomae, Attorney-in-fact for Kemal Malik
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kemal Malik:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Director Common Stock 8.53K $28.2K $3.30 Jan 2, 2025 Direct
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 7.8K $6.16K $0.79 Jan 2, 2025 Direct
ACCELERON PHARMA INC Director Common Stock 0 $175.00 Nov 19, 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 Nov 19, 2021 Direct

Insider Reports Filed by Kemal Malik

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAC Cartesian Therapeutics, Inc. Jan 2, 2025 2 $0 4 Jan 6, 2025 Director
RNAC Cartesian Therapeutics, Inc. Jul 1, 2024 2 $0 4 Jul 3, 2024 Director
RNAC Cartesian Therapeutics, Inc. Jul 1, 2024 0 $0 3 Jul 3, 2024 Director
XLRN ACCELERON PHARMA INC Nov 19, 2021 3 $0 4 Nov 22, 2021 Director